SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart. (July 2018)
- Record Type:
- Journal Article
- Title:
- SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart. (July 2018)
- Main Title:
- SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart
- Authors:
- Lim, V.G.
Bell, R.M.
Arjun, S.
Kolatsi-Joannou, M.
Long, D.A.
Yellon, D.M. - Abstract:
- Is Part Of:
- Journal of molecular and cellular cardiology. Volume 120(2018)Supplement
- Journal:
- Journal of molecular and cellular cardiology
- Issue:
- Volume 120(2018)Supplement
- Issue Display:
- Volume 120, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 120
- Issue:
- 2018
- Issue Sort Value:
- 2018-0120-2018-0000
- Page Start:
- 27
- Page End:
- Publication Date:
- 2018-07
- Subjects:
- Cardiology -- Periodicals
Heart Diseases -- Periodicals
Molecular Biology -- Periodicals
Cardiologie -- Périodiques
Cardiology
Electronic journals
Periodicals
616.12 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00222828 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00222828 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00222828 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.yjmcc.2018.05.087 ↗
- Languages:
- English
- ISSNs:
- 0022-2828
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5020.690000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7115.xml